There aren't too many biotechs around that are as hot as Incyte Corporation (NASDAQ: INCY) is right now. Incyte's stock might be down a little year to date, but shares have surged since April. Can Incyte keep the momentum going in the new year? I think so. Here are three reasons why the biotech's stock could soar in 2017.
Different employers offer different ways for their workers to save for retirement, and SEP IRAs are one popular way that smaller businesses and self-employed individuals can set up a retirement plan. For 2017, the contribution limits for SEP IRAs are set to go up, giving those who make maximum use of SEP IRAs even more flexibility to boost their retirement savings.
Here are three of the week's top pieces of financial advice, gathered from around the web:
Endangered tax deductions Maximize your deductions now, said Laura Saunders at The Wall Street Journal, because "a Trump presidency means you could lose them." President-elect Donald Trump and House Republicans have both proposed plans to lower income-tax rates while reducing the value of many deductions and exemptions.